![Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-020-00312-6/MediaObjects/41392_2020_312_Fig2_HTML.png)
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy
![NF‐κB and HIF crosstalk in immune responses - D'Ignazio - 2016 - The FEBS Journal - Wiley Online Library NF‐κB and HIF crosstalk in immune responses - D'Ignazio - 2016 - The FEBS Journal - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/37e4426c-0693-43a7-85a6-d05fd647deb2/febs13578-fig-0001-m.jpg)
NF‐κB and HIF crosstalk in immune responses - D'Ignazio - 2016 - The FEBS Journal - Wiley Online Library
![The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis | Arthritis Research & Therapy | Full Text The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Far2457/MediaObjects/13075_2008_Article_2307_Fig2_HTML.jpg)
The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis | Arthritis Research & Therapy | Full Text
![Frontiers | Th17 and Cognitive Impairment: Possible Mechanisms of Action | Frontiers in Neuroanatomy Frontiers | Th17 and Cognitive Impairment: Possible Mechanisms of Action | Frontiers in Neuroanatomy](https://www.frontiersin.org/files/Articles/472237/fnana-13-00095-HTML/image_m/fnana-13-00095-g001.jpg)
Frontiers | Th17 and Cognitive Impairment: Possible Mechanisms of Action | Frontiers in Neuroanatomy
![The Cytokine IL-17A Limits Th17 Pathogenicity via a Negative Feedback Loop Driven by Autocrine Induction of IL-24 - ScienceDirect The Cytokine IL-17A Limits Th17 Pathogenicity via a Negative Feedback Loop Driven by Autocrine Induction of IL-24 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1074761320302776-fx1.jpg)
The Cytokine IL-17A Limits Th17 Pathogenicity via a Negative Feedback Loop Driven by Autocrine Induction of IL-24 - ScienceDirect
![Th17 Cells: Biology, Pathogenesis of Autoimmune and Inflammatory Diseases, and Therapeutic Strategies - ScienceDirect Th17 Cells: Biology, Pathogenesis of Autoimmune and Inflammatory Diseases, and Therapeutic Strategies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002944012003367-gr1.jpg)
Th17 Cells: Biology, Pathogenesis of Autoimmune and Inflammatory Diseases, and Therapeutic Strategies - ScienceDirect
![Limiting inflammation—the negative regulation of NF-κB and the NLRP3 inflammasome | Nature Immunology Limiting inflammation—the negative regulation of NF-κB and the NLRP3 inflammasome | Nature Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fni.3772/MediaObjects/41590_2017_Article_BFni3772_Fig1_HTML.jpg)
Limiting inflammation—the negative regulation of NF-κB and the NLRP3 inflammasome | Nature Immunology
![IL-23 and IL-1β Drive Human Th17 Cell Differentiation and Metabolic Reprogramming in Absence of CD28 Costimulation: Cell Reports IL-23 and IL-1β Drive Human Th17 Cell Differentiation and Metabolic Reprogramming in Absence of CD28 Costimulation: Cell Reports](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/6542c1ec-0f0a-4e0a-83ec-91f8f09fa72a/fx1.jpg)
IL-23 and IL-1β Drive Human Th17 Cell Differentiation and Metabolic Reprogramming in Absence of CD28 Costimulation: Cell Reports
![Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis | medRxiv Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2020/11/12/2020.11.09.20228502/F7.large.jpg)
Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis | medRxiv
![Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-020-00312-6/MediaObjects/41392_2020_312_Fig1_HTML.png)
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy
![Th17/IL-17 induces endothelial cell senescence via activation of NF-κB/p53/Rb signaling pathway | Laboratory Investigation Th17/IL-17 induces endothelial cell senescence via activation of NF-κB/p53/Rb signaling pathway | Laboratory Investigation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41374-021-00629-y/MediaObjects/41374_2021_629_Fig1_HTML.png)
Th17/IL-17 induces endothelial cell senescence via activation of NF-κB/p53/Rb signaling pathway | Laboratory Investigation
![Frontiers | The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside | Immunology Frontiers | The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside | Immunology](https://www.frontiersin.org/files/Articles/594735/fimmu-11-594735-HTML/image_m/fimmu-11-594735-g001.jpg)
Frontiers | The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside | Immunology
![TRIM25 Promotes TNF-α–Induced NF-κB Activation through Potentiating the K63-Linked Ubiquitination of TRAF2 | The Journal of Immunology TRIM25 Promotes TNF-α–Induced NF-κB Activation through Potentiating the K63-Linked Ubiquitination of TRAF2 | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/204/6/1499/F1.large.jpg)
TRIM25 Promotes TNF-α–Induced NF-κB Activation through Potentiating the K63-Linked Ubiquitination of TRAF2 | The Journal of Immunology
![IJMS | Free Full-Text | Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer | HTML IJMS | Free Full-Text | Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer | HTML](https://www.mdpi.com/ijms/ijms-21-08470/article_deploy/html/images/ijms-21-08470-g001.png)